MIFH
GNMK

Migdal Insurance & Financial Holdings’s GenMark Diagnostics, Inc GNMK Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-49,176
Closed -$1.18M – 704
2021
Q1 		$1.18M Buy
49,176
+30,517
+164% +$567K 0.01% 231
2020
Q4 		$272K Buy
+18,659
New +$247K ﹤0.01% 279

Migdal Insurance & Financial Holdings's GNMK Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 49,176 shares — an estimated $1.18M sold.

Migdal Insurance & Financial Holdings first reported a position in GNMK in Q4 2020 and held it in 2 quarters. The position peaked at $1.18M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 49,176 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.18M.
  • Migdal Insurance & Financial Holdings first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's GenMark Diagnostics, Inc position peaked at $1.18M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.